SCHEMBL5725941

SCHEMBL5725941

COc1ccccc1CC(=O)c1ccc(O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.68
TTR P02766 1/20 0.65
MAPT P10636 1/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TDP1 Q9NUW8 1/20 0.49
ATM Q13315 1/20 0.49
MAOB P27338 1/20 0.49
TAS2R14 Q9NYV8 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HDAC1 Q13547 1/20 0.48
TSHR P16473 1/20 0.48
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HTT P42858 1/20 0.47
CAPN1 P07384 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL597834 0.88 L3MBTL1 (0.69) L3MBTL1TTRMAPTMEN1KMT2A
SCHEMBL31040323 0.87 L3MBTL1 (0.72) L3MBTL1TTRTDP1MEN1KMT2A
SCHEMBL9057785 0.87 L3MBTL1 (0.72) L3MBTL1TTRTDP1MEN1KMT2A
SCHEMBL24603113 0.84 L3MBTL1 (0.65) L3MBTL1TTRMAPTALDH1A1TDP1
SCHEMBL24603004 0.83 L3MBTL1 (0.60) L3MBTL1TTRMAPTALDH1A1TDP1
SCHEMBL29270111 0.83 KMT2A (0.61) L3MBTL1TTRMAPTALDH1A1MEN1
SCHEMBL7209622 0.80 L3MBTL1 (0.58) L3MBTL1KDM4EALDH1A1LMNA
SCHEMBL9271624 0.79 LMNA (0.57) TTRMAPTALDH1A1TDP1MAOB
SCHEMBL236515 0.79 TTR (1.00) TTRMAPTKDM4EALDH1A1HSD17B10
SCHEMBL332837 0.78 TTR (0.66) L3MBTL1TTRMAPTALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1705169-A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators Hormos Medical Ltd. (FI) 2006-09-27 EP disclosed
EP-1235776-B1 TRIPHENYLALKENE DERIVATIVES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS HORMOS MEDICAL CORP (FI) 2006-02-08 EP disclosed
US-6875775-B2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators HORMOS MEDICAL OY LTD (FI) 2005-04-05 US disclosed
US-6576645-B1 Such as 3-(4-chloro-1-(4-(2-(2-hydroxyethoxy)ethoxy)phenyl)--2-phenylbut-1 -enyl)phenol; producing tissue specific estro-genic and/or antiestrogenic effect HORMOS MEDICAL OY LTD (FI) 2003-06-10 US disclosed
EP-1235776-A1 TRIPHENYLALKENE DERIVATIVES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS Hormos Medical Corporation (FI) 2002-09-04 EP disclosed
WO-2001036360-A1 TRIPHENYLALKENE DERIVATIVES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS HORMOS MEDICAL CORPORATION (FI) 2001-05-25 WO disclosed